LoginRegister
    Sandoz launches SYMJEPI epinephrine syringe in the USSandoz launches SYMJEPI epinephrine syringe in the US
    Valeo Pharma and Zambon announces the approval of Onstryv for treatment of Parkinsons diseaseValeo Pharma and Zambon announces the approval of Onstryv for treatment of Parkinsons disease
    Major Relief- No Sales Tax on drugs, implants consumables used treatment says Kerala HCMajor Relief- No Sales Tax on drugs, implants consumables used treatment says Kerala HC
    Aurobindo arm to acquire 7 oncology drug from Spectrum for $300 millionAurobindo arm to acquire 7 oncology drug from Spectrum for $300 million
    Dr ReddyDr Reddy's gets four observations from USFDA for Andhra plant
    Biomunex signs licensing agreement with Sanofi for development of antibodiesBiomunex signs licensing agreement with Sanofi for development of antibodies
    Immunomedics sacituzumab fails to win accelerated approval from the FDAImmunomedics sacituzumab fails to win accelerated approval from the FDA
    More trouble for Sun Pharma: Tumbles after fresh allegations by whistleblowerMore trouble for Sun Pharma: Tumbles after fresh allegations by whistleblower
    80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry80 more Fixed Dose Drugs including Antibiotics, Hypertension Combos Banned by Health Ministry
    Zydus receives final approval from the USFDA for Acetazolamide ER CapsulesZydus receives final approval from the USFDA for Acetazolamide ER Capsules
    Suven Life Sciences secures Product Patents in Australia and SingaporeSuven Life Sciences secures Product Patents in Australia and Singapore
    Exelixis gets USFDA approval to CABOMETYX tablets for previously treated HCCExelixis gets USFDA approval to CABOMETYX tablets for previously treated HCC
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X